Clinical Trial Update: Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update from Celltrion evaluating AZM and AML, alone and in combination, for mild-to-moderate essential hypertension; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• AML
• AZM

Snippet

Sponsor: Celltrion | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED